Aclarion Announces Signing of Strategic Partnership Letter of Intent with ATEC to Advance Commercialization of Nociscan
The partnership aims to incorporate Aclarion’s Nociscan surgical decision technology into ATEC’s AlphaInformatiX platform to better inform spine surgery ATEC is a medical device company committed to revolutionizing the approach to spine surgery through clinical differentiation Aclarion’s Nociscan is the first augmented intelligence platform to measure biomarkers of intervertebral disc health in the lumbar spine,…
